INSIGHTS ON DRUG DEVELOPMENT
-
Predicting Softgel Stability And Shelf Life Using Accelerated Modeling
Predict ibuprofen softgel shelf life in 21 days instead of years. ASAPprime modeling identified PEG-ester degradants as the limiting factor, estimating 5.5-year and 3.8-year shelf lives before long-term studies concluded.
-
Engineering The Future Of Lipsomal Drug Delivery
Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.
-
CMC (Chemistry, Manufacturing and Controls) Management
Eliminate regulatory risks caused by fragmented data. Learn how a continuous data thread from bench to batch streamlines tech transfer and accelerates filing timelines.
-
How One Biotech Company Is Accelerating The Drug Discovery Workflow
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
Shining A Light On Dark Data6/11/2026
Centralizing data unlocks faster insights, reduces duplicated effort, and improves compliance. By overcoming silos and “dark data,” organizations can enable efficient search, reuse, and analysis.
-
Ask Us Anything: Mark Benger On Solid-State Strategies For Drug Development7/23/2026
Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.
-
Three Success Factors To Accelerate Your Program To Clinical Trial9/23/2026
Accelerating clinical timelines starts with a strong foundation. Discover how smart development strategies can reduce risk, conserve resources, and support future scale-up.
-
Comprehensive And Streamlined Genomic Signature Assessment6/9/2026
Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.
-
Scale-Up Of AAV Production In Fixed-Bed Bioreactors3/31/2026
Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.
DRUG DEVELOPMENT SOLUTIONS
-
Curia’s discovery biology team accelerates your program toward the clinic and commercialization with our best-in-class, customizable solutions.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
Observe how comprehensive R&D support advances therapeutic oligonucleotides from discovery through commercialization with tailored formulation development services across multiple modalities and delivery platforms.
-
Our team of analytical experts provides experience, efficiency, and technical proficiency in the development/validation of analytical methodology and GMP testing support for your project.
-
Allow you students to gain practical hands-on experience exploring the following fundamentals of mass spectrometry: